Medicine and Dentistry
DNA Methylation
76%
Clear Cell Renal Cell Carcinoma
21%
Transitional Cell Carcinoma
19%
Prognostication
19%
Neoplasm
16%
Carcinogenesis
15%
CpG Island
15%
Recurrent Disease
15%
Risk Evaluation
15%
Bacterial Artificial Chromosome
11%
Urothelium
10%
DNA (Cytosine 5) Methyltransferase 1
10%
Methylation
9%
Hepatocellular Carcinoma
9%
Malignant Neoplasm
9%
Kidney Tumour
9%
Prostate Cancer
8%
Renal Carcinogenesis
8%
Endometrial Cancer
8%
Liver Tissue
8%
Hepatitis Virus
7%
Nonalcoholic Fatty Liver
6%
Multivariate Analysis
5%
Overall Survival
5%
Adenocarcinoma
5%
Biopsy
5%
Magnetic Resonance Imaging
5%
Liver Carcinogenesis
5%
DNA Methyltransferase 3B
5%
Keyphrases
DNA Methylation (DNAm)
19%
DNA Methylation Profile
18%
Clear Cell Renal Cell Carcinoma (ccRCC)
17%
Precancerous
17%
Bacterial Artificial Chromosome
17%
Genome-wide DNA Methylation
14%
CpG Island
14%
DNA Methylation Status
12%
Renal Tissue
11%
Liver Tissue
10%
Renal Tumor
9%
Risk Estimation
9%
Renal Carcinogenesis
9%
Hepatocellular Carcinoma
9%
DNA Quantification
8%
Renal Cell Carcinoma
8%
Precancerous Conditions
8%
Array-based
7%
DNA Hypermethylation
7%
DNA Methylation Age
7%
Tumorous
6%
Kidney
6%
Patient Outcomes
6%
Non-cancer
5%
Methylation Status
5%
Poor Outcome
5%
Histological Subtypes
5%
High-performance Liquid Chromatography
5%
Tumorigenesis
5%
DNA Methylation Analysis
5%
Validation Cohort
5%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
100%
CpG Island
22%
Carcinogenesis
21%
Genetics
16%
Bacterial Artificial Chromosome
16%
Epigenetics
15%
CpG Site
10%
Epigenome
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
DNA Hypomethylation
7%
Gene Expression
6%
Alpha 1-Antitrypsin
6%
Epigenomics
6%
Tumor-Related Gene
5%
Bisulfite Sequencing
5%
Array Comparative Genomic Hybridization
5%
Recurrence Free Survival
5%
Survival Rate
5%
Overall Survival
5%
Cell Proliferation
5%